85 related articles for article (PubMed ID: 16282687)
21. Admission markers predict lacunar and non-lacunar stroke in young patients.
Zhang B; Zhang W; Li X; Pu S; Yin J; Yang N; Yi Y; Gao Q; Gao C
Thromb Res; 2011 Jul; 128(1):14-7. PubMed ID: 21429566
[TBL] [Abstract][Full Text] [Related]
22. Baseline serum urate and 90-day functional outcomes following acute ischemic stroke.
Dawson J; Lees KR; Weir CJ; Quinn T; Ali M; Hennerici MG; Walters MR
Cerebrovasc Dis; 2009; 28(2):202-3. PubMed ID: 19571532
[No Abstract] [Full Text] [Related]
23. Ischemic lesion volume correlates with long-term functional outcome and quality of life of middle cerebral artery stroke survivors.
Schiemanck SK; Post MW; Kwakkel G; Witkamp TD; Kappelle LJ; Prevo AJ
Restor Neurol Neurosci; 2005; 23(3-4):257-63. PubMed ID: 16082082
[TBL] [Abstract][Full Text] [Related]
24. Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke.
Welsh P; Barber M; Langhorne P; Rumley A; Lowe GD; Stott DJ
Cerebrovasc Dis; 2009; 27(3):247-53. PubMed ID: 19176958
[TBL] [Abstract][Full Text] [Related]
25. Favorable functional outcomes in acute ischemic stroke patients with subclinical hypothyroidism.
Akhoundi FH; Ghorbani A; Soltani A; Meysamie A
Neurology; 2011 Jul; 77(4):349-54. PubMed ID: 21715712
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly.
Denti L; Annoni V; Cattadori E; Salvagnini MA; Visioli S; Merli MF; Corradi F; Ceresini G; Valenti G; Hoffman AR; Ceda GP
Am J Med; 2004 Sep; 117(5):312-7. PubMed ID: 15336580
[TBL] [Abstract][Full Text] [Related]
27. IL-6: an early marker for outcome in acute ischemic stroke.
Waje-Andreassen U; Kråkenes J; Ulvestad E; Thomassen L; Myhr KM; Aarseth J; Vedeler CA
Acta Neurol Scand; 2005 Jun; 111(6):360-5. PubMed ID: 15876336
[TBL] [Abstract][Full Text] [Related]
28. Relationship between ankle brachial index (ABI), high sensitivity C-reactive protein (hs-CRP) and initial disability level in acute ischemic stroke.
Chotik-anuchit S; Nilanont Y; Poungvarin N
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S94-8. PubMed ID: 21728273
[TBL] [Abstract][Full Text] [Related]
29. Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome.
Basic Kes V; Simundic AM; Nikolac N; Topic E; Demarin V
Clin Biochem; 2008 Nov; 41(16-17):1330-4. PubMed ID: 18801351
[TBL] [Abstract][Full Text] [Related]
30. Serial measurements of N-terminal pro-brain natriuretic peptide after acute ischemic stroke.
Jensen JK; Mickley H; Bak S; Korsholm L; Kristensen SR
Cerebrovasc Dis; 2006; 22(5-6):439-44. PubMed ID: 16912478
[TBL] [Abstract][Full Text] [Related]
31. Hyperthermia is a surrogate marker of inflammation-mediated cause of brain damage in acute ischaemic stroke.
Leira R; Rodríguez-Yáñez M; Castellanos M; Blanco M; Nombela F; Sobrino T; Lizasoain I; Dávalos A; Castillo J
J Intern Med; 2006 Oct; 260(4):343-9. PubMed ID: 16961671
[TBL] [Abstract][Full Text] [Related]
32. Proinflammatory reactants as determinants of stroke severity in elderly.
Shakarishvili R; Beridze M
Georgian Med News; 2008 Sep; (162):23-7. PubMed ID: 18830025
[TBL] [Abstract][Full Text] [Related]
33. [Changes in autonomic control of heart rate after ischemic cerebral stroke].
Lakusić N; Mahović D; Babić T; Sporis D
Acta Med Croatica; 2003; 57(4):269-73. PubMed ID: 14639860
[TBL] [Abstract][Full Text] [Related]
34. Nicergoline increases serum substance P levels in patients with an ischaemic stroke.
Nishiyama Y; Abe A; Ueda M; Katsura K; Katayama Y
Cerebrovasc Dis; 2010 Jan; 29(2):194-8. PubMed ID: 20029189
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic accuracy of the Barthel Index for measuring activities of daily living outcome after ischemic hemispheric stroke: does early poststroke timing of assessment matter?
Kwakkel G; Veerbeek JM; Harmeling-van der Wel BC; van Wegen E; Kollen BJ;
Stroke; 2011 Feb; 42(2):342-6. PubMed ID: 21183748
[TBL] [Abstract][Full Text] [Related]
36. Nucleosomes in serum of patients with benign and malignant diseases.
Holdenrieder S; Stieber P; Bodenmüller H; Busch M; Fertig G; Fürst H; Schalhorn A; Schmeller N; Untch M; Seidel D
Int J Cancer; 2001 Mar; 95(2):114-20. PubMed ID: 11241322
[TBL] [Abstract][Full Text] [Related]
37. Nucleosomes in serum as a marker for cell death.
Holdenrieder S; Stieber P; Bodenmüller H; Fertig G; Fürst H; Schmeller N; Untch M; Seidel D
Clin Chem Lab Med; 2001 Jul; 39(7):596-605. PubMed ID: 11522104
[TBL] [Abstract][Full Text] [Related]
38. Nucleosomes indicate the in vitro radiosensitivity of irradiated bronchoepithelial and lung cancer cells.
Holdenrieder S; Stief J; Bergner A; Gamarra F; Mitlewski A; Nagel D; Huber RM; Stieber P
Tumour Biol; 2004; 25(5-6):321-6. PubMed ID: 15627898
[TBL] [Abstract][Full Text] [Related]
39. Circulating nucleosomes and biomarkers of immunogenic cell death as predictive and prognostic markers in cancer patients undergoing cytotoxic therapy.
Stoetzer OJ; Wittwer C; Lehner J; Fahmueller YN; Kohles N; Fersching DM; Leszinski G; Roessner J; Holdenrieder S
Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S217-24. PubMed ID: 22620489
[TBL] [Abstract][Full Text] [Related]
40. Nucleosomes in colorectal cancer patients during radiochemotherapy.
Kremer A; Holdenrieder S; Stieber P; Wilkowski R; Nagel D; Seidel D
Tumour Biol; 2006; 27(5):235-42. PubMed ID: 16864976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
